Company · CIK 0000001800 · SIC 2834 — Pharmaceutical Preparations · NYSE
ABBOTT LABORATORIES · ABT
Insider activity reported against this company. All insider holders · Files at: MYL, AQB. On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 23, 2026 FForm 4 → | Sep 25, 5:21 pm EDT | Kevin T ConroyDirector | 52,507 | $103.99 | $5,460,203 | 81,230 | — | |
| Sep 2, 2026 SForm 4 → | Sep 3, 6:11 pm EDT | John A. McCoy Jr.VICE PRESIDENT AND CONTROLLER | 27 | $109.54 | $2,958 | 24,549 | −0.11% | |
| Sep 1, 2026 FForm 4 → | Sep 3, 6:11 pm EDT | John A. McCoy Jr.VICE PRESIDENT AND CONTROLLER | 52 | $110.36 | $5,739 | 24,576 | — | |
| Sep 1, 2026 FForm 4 → | Sep 3, 6:02 pm EDT | Philip P BoudreauEVP AND CFO | 388 | $110.36 | $42,820 | 70,784 | — |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.
Filed by this entity as an insider elsewhere — common stock
No reported common-stock activity in this period.
Filed by this entity as an insider elsewhere — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.